HSA — authorised 20 July 2021
- Marketing authorisation holder: ALBIREO PHARMA INC
- Status: likely_approved
HSA authorised Bylvay on 20 July 2021
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 20 July 2021.
ALBIREO PHARMA INC holds the Singaporean marketing authorisation.